G1 Therapeutics Inc (GTHX)
3.31
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
3.305
0.00 (0.00%)
Pre-Market: 20:00
G1 Therapeutics Revenue (Annual): 82.51M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.51M |
| December 31, 2022 | 51.30M |
| December 31, 2021 | 31.48M |
| December 31, 2020 | 45.28M |
| December 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | 0.522M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
31.48M
Minimum
2021
82.51M
Maximum
2023
52.64M
Average
48.29M
Median
Revenue (Annual) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.854M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |